Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Inception |
|---|---|---|---|---|---|---|---|---|
| TRVI (Trevi Therapeutics, Inc.) | 62.86% | 131.38% | 26.95% | 4.32% | NA | NA | NA | -2.66% |
Data as of 07/16/2025, AR inception is 05/07/2019
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| TRVI (Trevi Therapeutics, Inc.) | 05/07/2019 | 07/16/2025 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Inception | YTD | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 8.75 | 131.38 | 26.95 | 4.32 | NA | NA | NA | -2.66 | 62.86 | 218.66 | -30.57 | 147.44 | -67.77 | -35.47 | -52.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sharpe Ratio | NA | 1.62 | 0.24 | 0.00 | NA | NA | NA | -0.05 | 1.87 | 2.66 | -0.44 | 1.26 | -1.01 | -0.26 | -0.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Standard Deviation(%) | NA | 80.18 | 80.02 | 86.86 | NA | NA | NA | 97.40 | 75.17 | 80.72 | 79.90 | 116.67 | 66.86 | 136.33 | 96.26 | NA | NA | NA | NA | NA | NA | NA |
| Draw Down(%) | NA | 29.06 | 75.23 | 93.03 | NA | NA | NA | 95.45 | 22.52 | 34.05 | 69.19 | 64.02 | 80.85 | 70.85 | 72.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 07/16/2025, AR inception is 05/07/2019
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| TRVI (Trevi Therapeutics, Inc.) |
-30.05%
Sep 2019 - Sep 2022 |
-16.86%
Jun 2019 - Jun 2024 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| TRVI (Trevi Therapeutics, Inc.) |
91.86%
Feb 2022 - Feb 2025 |
19.21%
Apr 2020 - Apr 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart